Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
SANTA CLARA, CA / ACCESSWIRE / June 1, 2023 / Graid Technology, makers of the revolutionary next-generation NVMe RAID controller SupremeRAID™️, has been awarded the…
LAMONE, SWITZERLAND / ACCESSWIRE / May 31, 2023 / Datamars, a leading Swiss global supplier of high-performance identification and data-based management solutions for the companion…
BERLIN, GERMANY / ACCESSWIRE / May 25, 2023 / “Wasel for Awareness and Education”, based in Jordan, is one of ten global grassroots initiatives recognized…
DUBAI, ARAB EMIRATES / ACCESSWIRE / May 24, 2023 / Piers Dunhill and Alessandra von Bismarck attended the WOW Summit in March of 2023 in…
GENEVA, SWITZERLAND / ACCESSWIRE / May 22, 2023 / The crucial topics of micronutrient deficiencies and Large Scale Food Fortification (LSFF) will be discussed at…
mindzie integrates AI ChatBot, enabling users to search for process insights the way they ask a business question. DALLAS, TX / ACCESSWIRE / May 23,…
WALTHAM, MA / ACCESSWIRE / May 24, 2023 / Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA…
Latest News
Moderna has initiated a Phase 1 clinical trial for an experimental vaccine targeting Bundibugyo ebolavirus in Canada. The first participant received the mRNA-1469 vaccine on August 3 at a facility in Truro, Nova Scotia. This development occurs as the virus persists in spreading across multiple provinces within the Democratic Republic of the Congo. The World Health Organization has classified the situation as a public health emergency of international concern.


